Início › Leucemia › Pensilvânia › Philadelphia
Ensaios clínicos de Leucemia em Philadelphia, PA
12 estudos para Leucemia estão buscando participantes em locais em Philadelphia e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RecrutandoEstudo observacional
- Children's Hospital of Philadelphia, Philadelphia
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
RecrutandoFase 1/2
- University of Pennsylvania, Philadelphia
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
RecrutandoFase 1
- Children's Hospital of Philadelphia, Philadelphia
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RecrutandoFase 3
- University of Pennsylvania, Philadelphia
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
RecrutandoFase 2
- Children's Hospital of Philadelphia, Philadelphia
Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies
RecrutandoEstudo observacional
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia
RecrutandoFase 1
- Children's Hospital of Philadelphia, Philadelphia
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RecrutandoEstudo observacional
- Saint Christopher's Hospital for Children, Philadelphia
Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
RecrutandoFase 1/2
- Children's Hospital of Philadelphia, Philadelphia
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RecrutandoFase 1
- Hospital of the University of Pennsylvania, Philadelphia
Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC
RecrutandoFase 1 inicial
- Children's Hospital of Philadelphia, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Philadelphia
Ensaios de Leucemia em outras cidades
- Houston, TX28 estudos
- Boston, MA25 estudos
- New York City, NY19 estudos
- Los Angeles, CA16 estudos
- Chicago, IL16 estudos
- Durham, NC13 estudos
- Baldwin Park, CA12 estudos
- Columbus, OH12 estudos
- Nashville, TN12 estudos
- Milwaukee, WI11 estudos
- Atlanta, GA11 estudos
- Seattle, WA11 estudos
Outros estudos em Philadelphia
- Câncer (todos os tipos)59 estudos
- Câncer de Mama56 estudos
- Câncer de Pulmão de Não Pequenas Células51 estudos
- Câncer Metastático46 estudos
- Câncer Colorretal44 estudos
- Câncer de Ovário44 estudos
- Câncer de Próstata44 estudos
- Câncer de Pulmão36 estudos
- Leucemia Mieloide Aguda34 estudos
- Insuficiência Cardíaca31 estudos
- Câncer Endometrial28 estudos
- Depressão26 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.